Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR-511-3p in non-small cell lung cancer

被引:7
|
作者
Wang, Guihua [1 ,2 ]
Deng, Liyong [1 ]
Gong, Kuiyu [1 ]
Zhou, Peng [1 ]
Peng, Luogen [1 ]
Li, Chang [1 ]
机构
[1] South China Univ, Changsha Cent Hosp, Dept Oncol, Changsha, Peoples R China
[2] South China Univ, Changsha Cent Hosp, Dept Oncol, 161 Shaoshan South Rd, Changsha 410004, Peoples R China
关键词
circ_0003528; miR-511-3p; NSCLC; PDL1; EXPRESSION; PROGRESSION; PD-L1;
D O I
10.1002/tox.23768
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
BackgroundAccumulating evidence suggests that circular RNAs (circRNAs) play important regulatory roles in non-small cell lung cancer (NSCLC). At present, we aimed to explore the regulatory role of has_circ_0003528 (circ_0003528) in NSCLC. MethodsAlterations of circ_0003528 expression in NSCLC samples and cell lines were detected by real-time quantitative polymerase chain reaction (RT-qPCR). Impacts of circ_0003528 on NSCLC cell malignant transformation were analyzed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT), 5-ethynyl-2 '-deoxyuridine (EdU), flow cytometry, transwell invasion, and tube formation assays. Epithelial-mesenchymal transition (EMT)-related markers were detected with western blotting. Pro-inflammatory cytokines were detected by Enzyme-linked immunosorbent assay (ELISA). The regulation mechanism of circ_0003528 was verified by dual-luciferase reporter and RNA pull-down assays. The tumorigenesis role of circ_0003528 was verified by animal experiments. ResultsHigher levels of circ_0003528 were obtained in NSCLC samples and cell lines, and patients with high circ_0003528 expression had a worse prognosis. Silence of circ_0003528 decreased xenograft growth in mouse models and induced cell apoptosis and repressed cell viability, proliferation, invasion, EMT, angiogenesis, and immune escape in NSCLC cells in vitro. Mechanistically, circ_0003528 controlled programmed cell death ligand 1 (PDL1) expression through interaction with miR-511-3p. The inhibiting impacts of circ_0003528 knockdown on NSCLC cell malignant transformation and immune escape were weakened after miR-511-3p silencing. Moreover, PDL1 overexpression partially counteracted miR-511-3p upregulation-mediated suppression on NSCLC cell malignant transformation and immune escape. ConclusionsCirc_0003528 facilitated NSCLC cell malignant transformation and immune escape through regulation of the miR-511-3p/PDL1 axis, highlighting the oncogenic role of circ_0003528 in NSCLC.
引用
收藏
页码:1347 / 1360
页数:14
相关论文
共 50 条
  • [21] Exosome-Derived hsa_circ_0005741 Promotes Malignant Progression of Non-Small Cell Lung Cancer by Mediating the MiR-1251-5p/YAP1 Pathway
    He, Yihua
    Wu, Shuting
    Zhi, Jiazhi
    Wei, Hailin
    Chen, Jianwei
    Lin, Junping
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (07): : 3791 - 3802
  • [22] Hsa_circ_0072088 promotes non-small cell lung cancer progression through modulating miR-1270/TOP2A axis
    Sixuan Li
    Zhigang Cui
    Min Gao
    Yanan Shan
    Yihong Ren
    Yuxin Zhao
    Di Wang
    Tingyu Meng
    Hongxu Liu
    Zhihua Yin
    Cancer Cell International, 25 (1)
  • [23] Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137
    Xue, Min
    Hong, Weijun
    Jiang, Jun
    Zhao, Fang
    Gao, Xiwen
    RNA BIOLOGY, 2020, 17 (12) : 1811 - 1822
  • [24] Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
    Kim, Dong Ha
    Kim, HyeongRyul
    Choi, Yun Jung
    Kim, Seon Ye
    Lee, Jung-Eun
    Sung, Ki Jung
    Sung, Young Hoon
    Packd, Chan-Gi
    Jung, Min-kyo
    Han, Buhm
    Kim, Kunhee
    Kim, Woo Sung
    Nam, Soo Jeong
    Choi, Chang-Min
    Yun, Miyong
    Lee, Jae Cheol
    Rho, Jin Kyung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (8): : 1 - 13
  • [25] Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
    Dong Ha Kim
    HyeongRyul Kim
    Yun Jung Choi
    Seon Ye Kim
    Jung-Eun Lee
    Ki Jung Sung
    Young Hoon Sung
    Chan-Gi Pack
    Min-kyo Jung
    Buhm Han
    Kunhee Kim
    Woo Sung Kim
    Soo Jeong Nam
    Chang-Min Choi
    Miyong Yun
    Jae Cheol Lee
    Jin Kyung Rho
    Experimental & Molecular Medicine, 2019, 51 : 1 - 13
  • [26] Circ_0020123 Increases ZFX Expression to Facilitate Non-Small Cell Lung Cancer Progression by Sponging miR-142-3p
    Lu, Jiancong
    Ma, Ximiao
    Lin, Junhong
    Hou, Peifeng
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1687 - 1698
  • [27] Hsa_circ_0001666 promotes non-small cell lung cancer migration and invasion through miR-1184/miR-548I/AGO1 axis
    Wang, Xueting
    Li, Rui
    Feng, Lingxin
    Wang, Jing
    Qi, Qi
    Wei, Wenjie
    Yu, Zhuang
    MOLECULAR THERAPY ONCOLYTICS, 2022, 24 : 597 - 611
  • [28] hsa_circ_0058357 acts as a ceRNA to promote non-small cell lung cancer progression via the hsa-miR-24-3p/AVL9 axis
    Wei, Dongshan
    Sun, Lifang
    Feng, Wei
    MOLECULAR MEDICINE REPORTS, 2021, 23 (06)
  • [29] Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer
    Ye, Qing
    Singh, Salvi
    Qian, Peter R.
    Guo, Nancy Lan
    CANCERS, 2021, 13 (17)
  • [30] Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axis
    Ding, Li
    Feng, Yinan
    Li, Longguang
    CELL CYCLE, 2022, 21 (22) : 2433 - 2443